Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

SER

Serina Therapeutics Inc.

Jun 14 • 04:00PM ET

11.01

Dollar change +1.36
Percentage change 14.09	%

Healthcare • Biotechnology • USA • AMEX

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-13.72	Insider Own	25.96%	Shs Outstand	8.41M	Perf Week	10.10%
Market Cap	92.59M	Forward P/E	-	EPS next Y	-	Insider Trans	1.52%	Shs Float	6.23M	Perf Month	24.69%
Income	-14.80M	PEG	-	EPS next Q	-	Inst Own	1.37%	Short Float	0.15%	Perf Quarter	-19.73%
Sales	0.14M	P/S	661.39	EPS this Y	-	Inst Trans	-3.08%	Short Ratio	0.72	Perf Half Y	-14.93%
Book/sh	5.07	P/B	2.17	EPS next Y	-	ROA	-194.70%	Short Interest	0.01M	Perf Year	-43.12%
Cash/sh	0.04	P/C	272.34	EPS next 5Y	-	ROE	-	52W Range	7.86 - 35.17	Perf YTD	-18.69%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-12.67%	ROI	-240.23%	52W High	-68.69%	Beta	1.04
Dividend TTM	-	Quick Ratio	0.13	Sales past 5Y	-39.80%	Gross Margin	-20.42%	52W Low	40.08%	ATR (14)	1.22
Dividend Ex-Date	-	Current Ratio	0.13	EPS Y/Y TTM	-41.47%	Oper. Margin	-7014.08%	RSI (14)	59.32	Volatility	15.42% 12.73%
Employees	4	Debt/Eq	0.80	Sales Y/Y TTM	317.65%	Profit Margin	-10424.65%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.13	EPS Q/Q	-27.85%	Payout	-	Rel Volume	1.28	Prev Close	9.65
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	600.00%	Earnings	-	Avg Volume	12.56K	Price	11.01
SMA20	15.65%	SMA50	9.10%	SMA200	-32.28%	Trades		Volume	16,050	Change	14.09%

May-15-24 07:30AM	Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinsons Disease (GlobeNewswire)
May-14-24 04:05PM	Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights (GlobeNewswire) +11.13%
Apr-17-24 04:05PM	Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman (GlobeNewswire)
Mar-26-24 05:04PM	Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics (GlobeNewswire) -11.90%

Serina Therapeutics, Inc. operates as a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley on March 26, 2024 and is headquartered in Huntsville, AL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bailey Gregory	Director	May 30 '24	Buy	9.50	5,205	49,448	20,206	May 31 04:18 PM
Bailey Gregory	Director	May 29 '24	Buy	9.50	1,173	11,144	15,001	May 31 04:18 PM
Bailey Gregory	Director	May 28 '24	Buy	9.50	9,019	85,680	13,828	May 29 04:15 PM
Bailey Gregory	Director	May 23 '24	Buy	9.50	2,371	22,524	4,809	May 24 04:15 PM
MINTZ STEVEN	Director	May 21 '24	Buy	9.93	9,151	90,885	9,900	May 23 05:07 PM
Bailey Gregory	Director	May 21 '24	Buy	9.50	1,422	13,509	1,522	May 23 04:15 PM
Bailey Gregory	Director	May 21 '24	Buy	9.50	916	8,702	2,438	May 24 04:15 PM
MINTZ STEVEN	Director	May 20 '24	Buy	9.43	2,675	25,233	1,240	May 23 05:07 PM
Bailey Gregory	Director	May 20 '24	Buy	9.00	100	900	100	May 22 04:15 PM
MINTZ STEVEN	Director	May 17 '24	Buy	8.50	554	4,709	554	May 23 05:07 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SER

Serina Therapeutics Inc.

Upgrade your FINVIZ experience